96 related articles for article (PubMed ID: 26662954)
21. Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract.
Vikram R; Sandler CM; Ng CS
AJR Am J Roentgenol; 2009 Jun; 192(6):1481-7. PubMed ID: 19457808
[TBL] [Abstract][Full Text] [Related]
22. The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value.
Gontero P; Tizzani A; Muir GH; Caldarera E; Macaluso MP
Urol Res; 2001 Dec; 29(6):377-87. PubMed ID: 11828990
[TBL] [Abstract][Full Text] [Related]
23. Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
Weng WC; Huang YH; Yang SF; Wang SS; Kuo WH; Hsueh CW; Huang CH; Chou YE
Tumour Biol; 2016 May; 37(5):6971-7. PubMed ID: 26662954
[TBL] [Abstract][Full Text] [Related]
24. GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
Djukic T; Simic T; Radic T; Matic M; Pljesa-Ercegovac M; Suvakov S; Coric V; Pekmezovic T; Novakovic I; Dragicevic D; Savic-Radojevic A
Int Urol Nephrol; 2015 Apr; 47(4):625-30. PubMed ID: 25716313
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
26. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
[TBL] [Abstract][Full Text] [Related]
27. Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis.
Liu Y; Qing H; Su X; Wang C; Li Z; Liu S
Med Sci Monit; 2015 Sep; 21():2694-700. PubMed ID: 26356590
[TBL] [Abstract][Full Text] [Related]
28. Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma.
Su SC; Hsieh MJ; Chou YE; Fan WL; Yeh CB; Yang SF
Medicine (Baltimore); 2015 Aug; 94(34):e1396. PubMed ID: 26313784
[TBL] [Abstract][Full Text] [Related]
29. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
30. CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Chou YE; Hsieh MJ; Hsin CH; Chiang WL; Lai YC; Lee YH; Huang SC; Yang SF; Lin CW
PLoS One; 2014; 9(4):e93692. PubMed ID: 24699672
[TBL] [Abstract][Full Text] [Related]
31. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan.
Tung MC; Hsieh MJ; Wang SS; Yang SF; Chen SS; Wang SW; Lee LM; Lee WJ; Chien MH
PLoS One; 2014; 9(3):e91147. PubMed ID: 24608123
[TBL] [Abstract][Full Text] [Related]
32. Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population.
Sharma KL; Yadav A; Gupta A; Tulsayan S; Kumar V; Misra S; Kumar A; Mittal B
Tumour Biol; 2014 Mar; 35(3):2583-9. PubMed ID: 24186075
[TBL] [Abstract][Full Text] [Related]
33. Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells.
Di Cello F; Flowers VL; Li H; Vecchio-Pagán B; Gordon B; Harbom K; Shin J; Beaty R; Wang W; Brayton C; Baylin SB; Zahnow CA
Mol Cancer; 2013 Aug; 12():90. PubMed ID: 23919753
[TBL] [Abstract][Full Text] [Related]
34. Impacts of CA9 gene polymorphisms and environmental factors on oral-cancer susceptibility and clinicopathologic characteristics in Taiwan.
Chien MH; Yang JS; Chu YH; Lin CH; Wei LH; Yang SF; Lin CW
PLoS One; 2012; 7(12):e51051. PubMed ID: 23226559
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
